Eligibility of stroke units in Poland for administration of intravenous thrombolysis

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
A CzłonkowskaA Kobayashi

Abstract

Systemic thrombolysis treatment was approved in Poland in 2003 and should be performed in specialist stroke units (SU). We performed a survey to determine stroke service preparedness for thrombolysis treatment in Poland. We sent a questionnaire evaluating the neurological departments in Poland, where stroke patients are treated. We divided them into four categories: (i) class A SU (fulfilling criteria of the National Program for Stroke Prevention and Therapy and European Stroke Initiative guidelines), (ii) class B (conditionally fulfilling criteria), (iii) class C (not fulfilling criteria), and (iv) departments without SU. Only class A units are eligible for implementing thrombolysis. We obtained response from 194 of 222 (87.4%) departments; 90 (46.4%) declared having an SU. According to criteria, 20 class A, 56 class B, 14 class C. During one year, 71 208 patients were admitted to hospitals; 69,982 (98.2%) to neurological departments. A total of 10,959 (15.4%) were treated in class A SU, 23,650 (33.2%) in class B, 5153 (7.2%) in class C, whereas 30,220 (42.4%) in neurological departments without SU. Our survey showed that only 15.4% stroke patients in Poland are admitted to high-quality SU, where thrombolysis may potentially b...Continue Reading

References

Dec 14, 1995·The New England Journal of Medicine·UNKNOWN National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
Mar 1, 1994·Stroke; a Journal of Cerebral Circulation·A CzlonkowskaD B Hier
Oct 1, 1996·Journal of Internal Medicine·I Aboderin, G Venables
Jul 1, 1997·Neurology·P D LydenT G Brott
Mar 22, 2003·Cerebrovascular Diseases·Kjell AsplundUNKNOWN Riks-Stroke Collaboration
Mar 22, 2003·Cerebrovascular Diseases·Otto Busse
Mar 22, 2003·Cerebrovascular Diseases·Marc HommelAssia Jaillard
Mar 22, 2003·Cerebrovascular Diseases·Anna CzłonkowskaDanuta Ryglewicz
Mar 22, 2003·Cerebrovascular Diseases·Roberto SterziUNKNOWN PROSIT Collaborators
Mar 22, 2003·Cerebrovascular Diseases·Bent Indredavik
Mar 22, 2003·Cerebrovascular Diseases·Teresa P Melo, José M Ferro
Mar 22, 2003·Cerebrovascular Diseases·Dániel BereczkiIstván Fekete
Mar 22, 2003·Cerebrovascular Diseases·Martin Dennis
Mar 22, 2003·Cerebrovascular Diseases·Michael BraininUNKNOWN Austrian Stroke Registry for Acute Stroke Units
Jul 10, 2003·Lancet Neurology·Markku Kaste
Aug 2, 2003·Nature Medicine·Patrick Most, Walter J Koch
Oct 31, 2003·Cerebrovascular Diseases·UNKNOWN European Stroke Initiative Executive CommitteePhilip Bath
Jan 1, 1994·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·T WeissbeinD B Hier

❮ Previous
Next ❯

Citations

May 7, 2013·Clinical Neurology and Neurosurgery·P SobolewskiW M Nyka
Aug 19, 2008·International Journal of Stroke : Official Journal of the International Stroke Society·Anna CzlonkowskaIwona Sarzynska-Dlugosz
Aug 19, 2008·International Journal of Stroke : Official Journal of the International Stroke Society·Jeyaraj Durai PandianJagaralpudi M K Murthy
Sep 22, 2010·International Journal of Stroke : Official Journal of the International Stroke Society·Anna CzłonkowskaMarta Skowroñska
Nov 15, 2011·Acta Neurologica Scandinavica·G KozeraUNKNOWN Pomeranian Stroke Register collaborators
Sep 15, 2012·International Journal of Stroke : Official Journal of the International Stroke Society·Laura LentiLászló Csiba
Sep 3, 2013·Geriatrics & Gerontology International·Piotr SobolewskiMonika Sledzińska-Dźwigał
Jun 11, 2015·Journal of Clinical Pharmacy and Therapeutics·P SobolewskiW Nyka
May 12, 2015·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Piotr SobolewskiGrzegorz Kozera
Mar 19, 2014·Journal of the Neurological Sciences·Piotr SobolewskiMonika Sledzińska-Dźwigał
Jun 3, 2006·Stroke; a Journal of Cerebral Circulation·Maciej NiewadaUNKNOWN Polish National Stroke Prevention and Treatment Collaborative Group
Sep 2, 2018·Neurologia i neurochirurgia polska·Piotr SobolewskiWalenty M Nyka
Jun 29, 2014·Molecular Biology Reports·Lianbo Gao, Honghua Gao
Oct 17, 2020·Clinical Interventions in Aging·Piotr SobolewskiGrzegorz Kozera

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.